Shaping the Future of Nutraceutical Innovation with Akay Bioactives: A Fireside Chat with Dr Trisha Sugarek MacDonald

Trisha Sugarek MacDonald, PhD, Market Development Manager at Akay Bioactives, explains how the newly merged company is advancing nutraceutical innovation through strengthened thought leadership, vertical integration, cutting-edge science, and a commitment to sustainability and transparency. In this interview at SupplySide Global, Dr MacDonald highlights two clinically substantiated ingredients fueling this work. Tenzara™, a synergistic curcumin–Boswellia complex developed with FenuMat® technology, delivers enhanced absorption and formulation advantages for musculoskeletal support. She also touches on CardaMind™, a novel black cardamom extract positioned as a caffeine-free source of clean, fast mental energy—with great potential to disrupt both the nootropics and functional beverage markets.

Key Learning Objectives

• Explore how the merger that created Akay Bioactives combines deep botanical expertise with large-scale, science-driven manufacturing to deliver sustainable and vertically integrated nutraceutical solutions.
• Learn about Tenzara™, a clinically substantiated curcumin–Boswellia complex, and understand its potential applications for musculoskeletal comfort, joint support, and cellular resilience.
• Understand the science and market potential behind CardaMind™, a novel black cardamom extract for clean mental energy, with human clinical research forthcoming.